ScholarWorks@Gyeongsang National University

Browsing by Kim, DajungAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 2 of 2

SCIESCOPUS
A multicentre prospective phase II study of rituximab combined with bortezomib, lenalidomide and dexamethasone, followed by lenalidomide maintenance (R-VRD) in patients with Waldenström's macroglobulinaemia (KMM1803)

Jung, Sung-Hoon; Kim, Dajung; Lee, Je-Jung; Kim, Kihyun; Min, Chang-Ki; Lee, Jae Hoon; Lee, Won Sik; Lee, Ji Hyun; Lee, Gyeong Won; Kim, Min Kyoung, et al.

ArticleIssue Date2025CitationBritish Journal of HaematologyPublisherBlackwell Publishing Inc.
SCIESCOPUS
Multicenter Prospective Phase II Study of Rituximab Combined, Bortezomib, Lenalidomide, Dexamethasone Followed By Lenalidomide Maintenance (R-VRD) in Patients with Waldenstrom's Macroglobulinemia (KMM1803)open access

Lee, Ho Sup; Kim, Dajung; Jung, Sung-Hoon; Lee, Je-Jung; Kim, Kihyun; Min, Chang-Ki; Lee, Jae Hoon; Lee, Won-Sik; Lee, JiHyun; Lee, Gyeong Won, et al.

ArticleIssue Date2023CitationBlood, v.142PublisherAmerican Society of Hematology
1

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어